Ariful Qadri

433 total citations
7 papers, 347 citations indexed

About

Ariful Qadri is a scholar working on Molecular Biology, Surgery and Pharmacology. According to data from OpenAlex, Ariful Qadri has authored 7 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Surgery and 2 papers in Pharmacology. Recurrent topics in Ariful Qadri's work include Pharmacological Effects of Natural Compounds (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers) and Lipid metabolism and biosynthesis (2 papers). Ariful Qadri is often cited by papers focused on Pharmacological Effects of Natural Compounds (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers) and Lipid metabolism and biosynthesis (2 papers). Ariful Qadri collaborates with scholars based in United States, France and Canada. Ariful Qadri's co-authors include James F. Tobin, Mylène Perreault, Ruth E. Gimeno, Seung Hahm, Lori D. Klaman, Jingsong Cao, Yingjiang Zhou, Leslie E. Stolz, Vipin Suri and Juli E. Jones and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Medicinal Chemistry.

In The Last Decade

Ariful Qadri

7 papers receiving 343 citations

Peers

Ariful Qadri

MB

BIOCH

EDM

PHYSI

SURGE

A K Okwu United States

Gaëlle Filhoulaud France

Heinrich Iber Germany

Ulla Karlsson Sweden

Nina Mayorek Israel

Emily R. Greene United States

Shahzad Siddiqi United States

H Nishino Japan

Sean Myers-Payne United States

Judy Parker United States

A K Okwu United States

Ariful Qadri

204 ×0.9

MB

75 ×0.7

BIOCH

30 ×0.4

EDM

82 ×1.2

PHYSI

80 ×1.4

SURGE

Citations per year, relative to Ariful Qadri Ariful Qadri (= 1×) peers A K Okwu

Countries citing papers authored by Ariful Qadri

Since Specialization

Citations

This map shows the geographic impact of Ariful Qadri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariful Qadri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariful Qadri more than expected).

Fields of papers citing papers by Ariful Qadri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ariful Qadri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariful Qadri. The network helps show where Ariful Qadri may publish in the future.

Co-authorship network of co-authors of Ariful Qadri

This figure shows the co-authorship network connecting the top 25 collaborators of Ariful Qadri. A scholar is included among the top collaborators of Ariful Qadri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ariful Qadri. Ariful Qadri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Cao, Jingsong, Bryan Goodwin, Qingcong Lin, et al.. (2014). Mice deleted for GPAT3 have reduced GPAT activity in white adipose tissue and altered energy and cholesterol homeostasis in diet-induced obesity. American Journal of Physiology-Endocrinology and Metabolism. 306(10). E1176–E1187. 42 indexed citations

2.

Perreault, Mylène, Feng Guo, Sarah Will, et al.. (2013). Activation of TrkB with TAM-163 Results in Opposite Effects on Body Weight in Rodents and Non-Human Primates. PLoS ONE. 8(5). e62616–e62616. 21 indexed citations

3.

Wan, Zhao‐Kui, Huan‐Qiu Li, Manus Ipek, et al.. (2012). Discovery of HSD-621 as a Potential Agent for the Treatment of Type 2 Diabetes. ACS Medicinal Chemistry Letters. 4(1). 118–123. 11 indexed citations

4.

Cao, Jingsong, Yingjiang Zhou, Xinyi Huang, et al.. (2011). Targeting Acyl-CoA:Diacylglycerol Acyltransferase 1 (DGAT1) with Small Molecule Inhibitors for the Treatment of Metabolic Diseases. Journal of Biological Chemistry. 286(48). 41838–41851. 119 indexed citations

5.

Wan, Zhao‐Kui, Jason Xiang, Huan‐Qiu Li, et al.. (2009). Efficacious 11β-Hydroxysteroid Dehydrogenase Type I Inhibitors in the Diet-Induced Obesity Mouse Model. Journal of Medicinal Chemistry. 52(17). 5449–5461. 48 indexed citations

6.

Stolz, Leslie E., et al.. (2006). Administration of myostatin does not alter fat mass in adult mice. Diabetes Obesity and Metabolism. 10(2). 135–142. 31 indexed citations

7.

Erbe, David V., Suyue Wang, Yanling Zhang, et al.. (2004). Ertiprotafib Improves Glycemic Control and Lowers Lipids via Multiple Mechanisms. Molecular Pharmacology. 67(1). 69–77. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact